Home Search
epidiolex - search results
If you're not happy with the results, please do another search
Epidiolex A Cash Machine For GW Pharmaceuticals
GW Pharmaceuticals estimates its net product sales for 2020 to have reached approximately USD $526 million - and its cannabidiol medicine made up the...
The Crazy-High Price Of Cannabidiol Medicine Epidiolex
If parents of children with severe epilepsy were hoping for a bit of compassion on the cost of the first FDA approved cannabis medicine,...
CBD Product Label Accuracy In The Spotlight Again
Yet another study has indicated many manufacturers of unregulated cannabidiol products need to lift their game on quality control.
Researchers from the University of Kentucky...
New GW Pharma Facility Construction Kicks Off
GW Pharmaceuticals' parent has announced construction of a new major cannabinoid manufacturing facility at the UK's Kent Science Park has commenced.
GW Pharma is the...
CBD Medicine Given TSC Green Light In The UK
Jazz Pharmaceuticals subsidiary GW Pharmaceuticals has announced it has received approval in the UK for the use of Epidyolex to manage seizures associated with...
GW Pharma Receives Queen’s Award For Cannabinoid Work
In what may be a first for a medical cannabis company, GW Pharmaceuticals has received the Queen’s Award for Enterprise 2021 in the Innovation...
Jazz Pharmaceuticals To Acquire GW Pharma
Jazz Pharmaceuticals is to acquire cannabinoid medicine manufacturer GW Pharmaceuticals for a whopping sum.
Founded in 1998, GW Pharmaceuticals manufactures CBD-based Epidiolex, which is marketed...
US FDA Outlines Plans For Collecting Better Cannabidiol Data
The U.S. Food and Drug Administration is still inching its way towards developing consumer protection standards relating to CBD.
Back in 2019, it appears it...
Cannabidiol CO2 Extraction Patent Action Launched
Canada's Canopy Growth is taking on the UK's GW Pharmaceuticals over a widely used cannabidiol extraction method.
The company recently filed its complaint in the...
Brexit’s Medical Cannabis Sting For UK Paediatric Patients
The UK’s Brexit transition period ends on 1 January 2021, and with it access to medical cannabis prescriptions filled in the EU.
From January 1,...
Advertisement
